DELVE

The latest episode of Science Friday features an interview with Delve Founder, Joe DeRisi, PhD, who discusses his work solving "medical mysteries" and how Delve can help treat patients with no clear explanation for their symptoms... As exclusive licensee of University of California San Francisco's (UCSF) metagenomic sequencing (mNGS) technology, Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases... Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases. We are a well-funded stealth biotech company backed by some of the most experienced operators and investors in the biotech industry.

Also known as: Delve Bio